Small intestine cancer & celiac disease «
Links shared publicly online about this topic.
- 1,648total visits
Small intestine cancer & celiac disease «
View full resource at lapislight.com
Tags: Digestion, Celiac Disease, Intestine, Cancer, Small Intestine Cancer, Disease and Condition, disease
Most Recently Shared on October 26, 2009 at 11:33 pm By:
There is an increased risk of small bowel adenocarcinoma in patients with celiac disease. : http://bit.ly/3eg2xT via @addthis
Medical News: Mutation May Affect PFS in Lung Cancer - in , ELCC from MedPage Today
medpagetoday.com — “Medical News: Mutation May Affect PFS in Lung Cancer - in , ELCC from MedPage Today” View full resource at medpagetoday.com
Most Recently Shared on April 20, 2012 at 8:33 pm By:
Mutation May Affect PFS in #NSCLC. #ELCC http://t.co/0gGykteS
ELCC 2012: New analysis helps guide use of erlotinib in advanced non-small cell lung cancer
ecancer.org — “ELCC 2012: New analysis helps guide use of erlotinib in advanced non-small cell lung cancer” View full resource at ecancer.org
Most Recently Shared on April 18, 2012 at 2:11 pm By:
ecancer Oncology and Health News
#ELCC News: New analysis helps guide use of erlotinib in advanced non-small cell lung cancer http://t.co/g4aoiLZc #lungcancer
Memory Problems After Cancer: 'Chemo Brain' May Not Be Sole Cause, Study Suggests
huffingtonpost.com — “There may be more than one factor responsible for "chemo brain" -- the term used for memory and attention impairments often experienced after undergoing chemotherapy for cancer, according to a small new study. Researchers from the University of Missouri found that women who had breast cancer surgery but had not yet undergone chemotherapy also experienced similar memory problems.” View full resource at huffingtonpost.com
Most Recently Shared on April 13, 2012 at 12:01 pm By:
Raymond DuBois Physician, Doctor, Internist, Gastroenterologist, and Health Executive
"Chemo Brain" May Be Caused By More Than Chemotherapy: http://t.co/s019i332 via
Nanoparticle-delivered RNA interference drug stops head and neck cancer growth
phys.org — “(Phys.org) -- A nanoparticle drug delivery vehicle for small interfering RNA molecules (siRNA), that is already being tested in human clinical trials, now shows promise for the treatment of head and neck cancer. Dong Shin, of Emory University, and Mark E. Davis, of the Nanosystems Biology Cancer Center ...” View full resource at phys.org
Most Recently Shared on April 6, 2012 at 2:07 pm By:
Nanoparticle-delivered RNA interference drug stops head and neck cancer growth http://t.co/Sa7qTaiC
Study assesses link between antifolate medications, KRAS mutations and amplification
news-medical.net — “Testing patients with non-small cell lung cancer for both mutations and amplifications of the KRAS gene prior to therapy may help to predict response to treatment with antifolates, according to the updated results of a preclinical study presented at the AACR Annual Meeting 2012, held here March 31 - April 4.” View full resource at news-medical.net
Most Recently Shared on April 5, 2012 at 11:29 am By:
Lung Cancer News: Study assesses link between antifolate medications, KRAS mutations and amplification: Testing ... http://t.co/pTIigUcV
Belagenpumatucel-L improves survival for patients with stage 3B/4 NSCLC
news-medical.net — “Long-term follow-up of a phase II clinical trial showed encouraging survival in some patients with stage 3B/4 non-small cell lung cancer treated with belagenpumatucel-L, a therapeutic vaccine.” View full resource at news-medical.net
Most Recently Shared on April 5, 2012 at 11:29 am By:
Lung Cancer News: Belagenpumatucel-L improves survival for patients with stage 3B/4 NSCLC: Long-term follow-up o... http://t.co/f8eeFaIJ
Combination treatment shows promise against NSCLC patients ineligible for bevacizumab
news-medical.net — “A combination of nab-paclitaxel and carboplatin for the treatment of non-small cell lung cancer may be a promising option for patients ineligible for treatment with bevacizumab, according to data presented at the AACR Annual Meeting 2012, held here March 31 - April 4.” View full resource at news-medical.net
Most Recently Shared on April 4, 2012 at 11:27 am By:
Lung Cancer News: Combination treatment shows promise against NSCLC patients ineligible for bevacizumab: A combi... http://t.co/vU5W9EYs
Stem Cells From Intestinal Crypt Lead Researchers To Cancer Discovery
medicalnewstoday.com — “Tales from the crypt are supposed to be scary, but new research from Vanderbilt University, the HudsonAlpha Institute for Biotechnology and colleagues shows that crypts can be places of renewal to” View full resource at medicalnewstoday.com
Most Recently Shared on April 3, 2012 at 7:05 am By:
MNT Colorectal Canc Health News
Stem Cells From Intestinal Crypt Lead Researchers To Cancer Discovery http://t.co/K3kM27aZ #colorectalcancer
Seeking Clues To Colon Cancer In Newly Identified Stem Cells
medicalnewstoday.com — “Vanderbilt-Ingram Cancer Center researchers have identified a new population of intestinal stem cells that may hold clues to the origin of colorectal cancer.This new stem cell population” View full resource at medicalnewstoday.com
Most Recently Shared on April 2, 2012 at 7:05 am By:
MNT Stem Cell News Health News
Seeking Clues To Colon Cancer In Newly Identified Stem Cells http://t.co/GSfez7ey #stemcell
2 targeted therapies act against Ewing's sarcoma tumors | Science Codex
sciencecodex.com — “CHICAGO - A pair of targeted therapies shrank tumors in some patients with treatment-resistant Ewing's sarcoma or desmoplastic small-round-cell tumors, according to research led by investigators from The University of Texas MD Anderson Cancer Center” View full resource at sciencecodex.com
Most Recently Shared on April 1, 2012 at 1:59 pm By:
Bruce Shriver Health Advocate, Patient Advocate, PhD, and Doctor
2 targeted therapies act against Ewing's sarcoma tumors - http://t.co/bwkMAS4b
Diversity of intestinal stem cells is greater than previously thought
news-medical.net — “Tales from the crypt are supposed to be scary, but new research from Vanderbilt University, the HudsonAlpha Institute for Biotechnology and colleagues shows that crypts can be places of renewal too: intestinal crypts, that is. Intestinal crypts are small areas of the intestine where new cells are formed to continuously renew the digestive tract. By focusing on one protein expressed in our intestines called Lrig1, the researchers have identified a special population of intestinal stem cells that ” View full resource at news-medical.net
Most Recently Shared on March 31, 2012 at 9:05 am By:
Diversity of intestinal stem cells is greater than previously thought: Tales from the crypt are supposed to be s... http://t.co/7dmOlUYG
Small amount of drinking can increase breast cancer risk | StarTribune.com
startribune.com — “Find lifestyle and features news & commentary from Minneapolis, St. Paul, the Twin Cities metro area and Minnesota.” View full resource at startribune.com
Most Recently Shared on March 29, 2012 at 3:30 pm By:
Small amount of drinking can increase breast cancer risk: Heavier drinking can up rish 50 percent. http://t.co/e2z2Y38k
To Combat Diabetes, Weight Loss Surgery Works Better Than Medicine, Studies Find - NYTimes.com
nytimes.com — “Bariatric surgery, in which the stomach is stapled and the small intestine rerouted, puts the disease into remission far more often than drugs, diet and exercise, researchers say.” View full resource at nytimes.com
Most Recently Shared on March 29, 2012 at 3:10 pm By:
To Combat #Diabetes, Weight Loss Surgery Works Better Than Medicine, Studies Find: http://t.co/qxgW7ay9
Robin Gibb Liver Cancer: Hospitalized After Intestinal Surgery | MyDocHub - Health News | Women’s, Men’s & Sex & Relationship
mydochub.com — “[caption id= align=alignnone width=468 caption=Robin Gibb Cancer][/caption] 62-year old Robin Gibb of the Bee Gees is recovering in the hospital ...” View full resource at mydochub.com
Most Recently Shared on March 29, 2012 at 12:38 am By:
Robin Gibb Liver Cancer: Hospitalized After Intestinal Surgery http://t.co/hpC9ouvd
Preoperative Chemotherapy Shows Promise in Early Lung Cancer
onclive.com — “Preoperative gemcitabine plus cisplatin followed by radical surgery is feasible, tolerable, and active in patients with early-stage non-small cell lung cancer.” View full resource at onclive.com
Most Recently Shared on March 28, 2012 at 2:08 pm By:
Preoperative Chemotherapy Shows Promise in Early Lung Cancer http://t.co/yEJ2P6Sg
Advertisement
